Abstract:Objective: Brain radiotherapy often results in impairment of hypothalamic-pituitary (HT-P) function, which in turn causes secretory dysfunction of related hormones. In this paper, the frequency of metastasis in the HT-P area and its high-risk factors in patients with brain metastasis were retrospectively analyzed, and thus provide experimental evidence for protecting HT-P area during whole brain radiotherapy (WBRT). Methods: A retrospective analysis was performed on the data of patients with brain metastasis diagnosed by cranial magnetic resonance imaging (MRI) at the First Hospital of Lanzhou University from 2017 to 2020. The anatomical positions of the hypothalamus and pituitary were delineated, followed by their expansion by 5 mm outwards, respectively, in the three-dimensional direction, and the hypothalamus +5 mm and pituitary +5 mm were obtained as the avoidance area, in which the frequency of brain metastasis was evaluated. Univariate and multivariate logistic regression models were used to analyze the high risk factors of brain metastasis in HT-P area. Results: A total of 3,375 brain metastatic lesions from 411 patients were included in the analysis. The rates of brain metastasis in the hypothalamus +5 mm and pituitary +5 mm in the whole group of cases were 2.9% (12/411) and 1.5% (6/411) respectively; the frequency of lesions was 0.4% (13/3375) and 0.2% (6/3375) respectively. Univariate and multivariate analyses showed that the number of brain metastases (OR = 14.946; 95% CI = 4.071-54.880; p < 0.001), and the occurrence of brain metastasis in the pituitary (OR = 13.331; 95% CI = 1.511-117.620; p = 0.020) were related to brain metastasis in the hypothalamus, and that the only relevant factor for brain metastasis in the pituitary was the occurrence of that in the hypothalamus (OR = 0.069; 95% CI = 0.010-0.461; p = 0.006). There was no correlation between tumor pathological types, the maximum diameter, the total volume of brain metastatic lesions and the risk of brain metastasis in hypothalamus and pituitary. Conclusion: The frequency of brain metastasis in the HT-P area is extremely low. The risk of brain metastases in the hypothalamus is correlated with their number. The larger the number of metastatic lesions, the higher the frequency of brain metastasis. Protection of the HT-P area during WBRT may be unlikely to compromise the tumor recurrence rate for patients with a relatively small number of brain metastases.

Related characteristics and research progress of tumors affecting hypothalamic hormone secretion

The Development of the Researches about the Mechanisms of Paraneoplastic Rheumatic Syndromes

Hormone supply to the pituitary gland: A comprehensive investigation of female‐related tumors (Review)

The clinical and MRI features of tumor involving the hypothalamus in children

Endocrine Disorder in Patients With Craniopharyngioma

A review of complex hormone regulation in thyroid cancer: novel insights beyond the hypothalamus-pituitary-thyroid axis

Model Roles of the Hypothalamo-Neurohypophysial System in Neuroscience Study

Hypothalamus-pituitary hormones and ovarian cancer

Frequency of metastases within the hypothalamic-pituitary area and the associated high-risk factors in patients with brain metastases

Neurologic manifestations of hypothalamic disease

Characteristics and Factors Influencing Hypothalamic Pituitary Dysfunction in Patients with Craniopharyngioma

The Stem Cell Connection of Pituitary Tumors

[Advances in Basic and Translational Research in Neuroendocrine Neoplasms].

Options and Prognosis in Treatment of Hypothalamic Hamartoma

Neural Circuitries between the Brain and Peripheral Solid Tumors

Advances in the role of nervous system in initiation and progression of tumors

Pathogenesis, clinical features, and treatment of plurihormonal pituitary adenoma

Socio-behavioral dysfunction in disorders of hypothalamic-pituitary involvement: The potential role of disease-induced oxytocin and vasopressin signaling deficits

Non-adenomatous Pituitary Tumours Mimicking Functioning Pituitary Adenomas

Research status and prospects of pituitary adenomas in conjunction with neurological and psychiatric disorders and the tumor microenvironment

Neuroendocrine regulations in tissue-specific immunity: From mechanism to applications in tumor